文献
J-GLOBAL ID:201702280579944201
整理番号:17A1065138
再発または難治性骨髄腫患者における自己幹細胞移植の高用量ゲムシタビン,ブスルファン,およびメルファラン:メルファランを用いた第2相試験とマッチドペア比較【Powered by NICT】
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
著者 (20件):
Nieto Yago
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Valdez Benigno C
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Pingali Sai R
(Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Bassett Roland
(Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Delgado Ruby
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Nguyen John
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Shah Nina
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Popat Uday
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Jones Roy B
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Andersson Borje S
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Gulbis Alison
(Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Ahmed Sairah
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Bashir Qaiser
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Parmar Simrit
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Patel Krina
(Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Myers Alan
(Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Rondon Gabriela
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Orlowski Robert Z
(Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Champlin Richard
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Qazilbash Muzaffar
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
資料名:
Lancet Haematology
(Lancet Haematology)
巻:
4
号:
6
ページ:
e283-e292
発行年:
2017年
JST資料番号:
W3150A
ISSN:
2352-3026
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)